Cryptococcosis, also known as cryptococcal disease, is a potentially fatal fungal disease. It is caused by one of two species; Cryptococcus neoformans and Cryptococcus gattii.
Cryptococcosis Treatment Market contains market size and forecasts of Cryptococcosis Treatment in Global, including the following market information:
- Global Cryptococcosis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cryptococcosis Treatment market was valued at 4137.4 million in 2021 and is projected to reach US$ 4882.1 million by 2028, at a CAGR of 2.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Amphotericin B Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cryptococcosis Treatment include Bristol-Myers Squibb, Abbott Laboratories, Pfizer, Glenmark Pharmaceuticals, Bausch Health, Johnson & Johnson, Novartis AG, Janssen Biotech and Sigmapharm Laboratories. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cryptococcosis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cryptococcosis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cryptococcosis Treatment Market Segment Percentages, by Type, 2021 (%)
- Amphotericin B
- Flucytosine
- Fluconazole
Global Cryptococcosis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cryptococcosis Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Drug Store
- Other
Global Cryptococcosis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cryptococcosis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Cryptococcosis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Cryptococcosis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bristol-Myers Squibb
- Abbott Laboratories
- Pfizer
- Glenmark Pharmaceuticals
- Bausch Health
- Johnson & Johnson
- Novartis AG
- Janssen Biotech
- Sigmapharm Laboratories
Industry Market Size
